EMDS Aspartate Aminotransferase (AST) 67657/95
by Em Diagnostic Systems, Inc.
510(k) K863963
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK863963 | Date28 Nov 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Emds(Tm) Aspartate Aminotransferase (Ast) 67657/95
- 510(k) Number
- FDA Product Code
- CIT
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1100
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The EMDS Aspartate Aminotransferase (AST) 67657/95 is a diagnostic device classified under Nadh Oxidation/Nad Reduction, Ast/Sgot (Product Code: CIT). It measures aspartate aminotransferase (AST) levels in blood samples, a key enzyme used to assess liver function and detect conditions such as hepatitis, cirrhosis, or muscle damage. AST assays are essential in clinical chemistry for evaluating hepatic and cardiac health, providing quantitative results to support diagnostic decision-making.
This device is intended for in vitro diagnostic use in clinical chemistry laboratories. Supplied as a single-use reagent, it requires proper storage under controlled conditions to maintain stability and accuracy. The device has received FDA 510(k) clearance under the Substantially Equivalent determination (K863963) and falls under Class II regulatory classification with special controls. Compliance with Regulation 862.1100 ensures adherence to performance standards for diagnostic reagents.
Other devices from Em Diagnostic Systems, Inc.
Questions
AI-generated answers, 1 Oct 2026
What clinical conditions does the EMDS AST 67657/95 help diagnose?
This reagent measures aspartate aminotransferase (AST) levels, a key enzyme for assessing liver function and detecting conditions like hepatitis, cirrhosis, or muscle damage. It also supports evaluation of cardiac health, as elevated AST can indicate myocardial injury. The quantitative results aid clinicians in diagnostic decision-making for hepatic and cardiac disorders.
How is the EMDS AST 67657/95 supplied, and what are its storage requirements?
The device is supplied as a single-use reagent, ensuring sterility and consistency for each test. It must be stored under controlled conditions to maintain stability and accuracy. Proper storage prevents degradation and ensures reliable performance, as outlined in the manufacturer’s instructions.
Is the EMDS AST 67657/95 intended for reuse, or is it designed for single-use?
This reagent is explicitly designed for single-use only. Single-use reagents minimize cross-contamination risk and ensure accurate, reproducible results for each patient sample. Reusing it could compromise sterility and reliability, so adherence to single-use guidelines is critical.
What regulatory pathway does the EMDS AST 67657/95 follow, and what does that mean for users?
The device received FDA 510(k) clearance under the Substantially Equivalent determination (K863963), classifying it as a Class II medical device with special controls. This means it meets performance standards for diagnostic reagents, ensuring compliance with Regulation 862.1100. Users can rely on its validated design and manufacturing processes for clinical chemistry applications.
Are there different models or sizes available for the EMDS AST 67657/95?
This specific device is identified by the model/reference number 67657/95, indicating a single, standardized formulation for AST measurement. No alternative models or sizes are referenced in the available data, so this reagent is provided uniformly for consistent clinical use.